LEADER 04034nam  2200685Ia 450 
001 9910966019903321
005 20251017110104.0
010   $a9786610176663
010   $a9780309166539
010   $a0309166535
010   $a9781280176661
010   $a1280176660
010   $a9780309528290
010   $a0309528291
035   $a(CKB)111090425020458
035   $a(EBL)3376301
035   $a(SSID)ssj0000210321
035   $a(PQKBManifestationID)11198356
035   $a(PQKBTitleCode)TC0000210321
035   $a(PQKBWorkID)10283674
035   $a(PQKB)10658734
035   $a(MiAaPQ)EBC3376301
035   $a(Au-PeEL)EBL3376301
035   $a(CaPaEBR)ebr10055396
035   $a(CaONFJC)MIL17666
035   $a(OCoLC)923262742
035   $a(Perlego)4737195
035   $a(DNLM)1200641
035   $a(BIP)9482771
035   $a(EXLCZ)99111090425020458
100   $a20031215d2004      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNew frontiers in contraceptive research $ea blueprint for action /$fSharyl J. Nass and Jerome F. Strauss III, editors ; Committee on New Frontiers in Contraceptive Research, Board on Health Sciences Policy
205   $a1st ed.
210   $aWashington, D.C. $cNational Academies Press$dc2004
215   $a1 online resource (xiv, 232 pages) $cillustrations
311 0 $a9780309091077 
311 0 $a0309091071 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Preface""; ""Contents""; ""Executive Summary""; ""1 Introduction""; ""2 Target Discovery and Validation""; ""3 Product Identification and Development""; ""4 Improving Contraceptive Use and Acceptability""; ""5 Capitalizing on Recent Scientific Advances""; ""APPENDIXES""; ""APPENDIX A--Examples of Progress and Impediments in Contraceptive Research and Development""; ""APPENDIX B--Agendas and Participants in Committee Workshops""; ""APPENDIX C--Committee Biographies""; ""Glossary""; ""Acronyms""
330   $aMore than a quarter of pregnancies worldwide are unintended. Between 1995 and 2000, nearly 700,000 women died and many more experienced illness, injury, and disability as a result of unintended pregnancy. Children born from unplanned conception are at greater risk of low birth weight, of being abused, and of not receiving sufficient resources for healthy development. A wider range of contraceptive options is needed to address the changing needs of the populations of the world across the reproductive life cycle, but this unmet need has not been a major priority of the research community and pharmaceutical industry. New Frontiers in Contraceptive Research: A Blueprint for Action , a new report from the Institute of Medicine of the National Academies, identifies priority areas for research to develop new contraceptives. The report highlights new technologies and approaches to biomedical research, including genomics and proteomics, which hold particular promise for developing new products. It also identifies impediments to drug development that must be addressed. Research sponsors, both public and private, will find topics of interest among the recommendations, which are diverse but interconnected and important for improving the range of contraceptive products, their efficacy, and their acceptability.
606   $aContraception$xResearch
606   $aBirth control$xResearch
615  0$aContraception$xResearch.
615  0$aBirth control$xResearch.
676   $a613.9/4/072
701   $aNass$b Sharyl J$0857626
701   $aStrauss$b Jerome F$g(Jerome Frank),$cIII,$f1947-$01746133
712 02$aInstitute of Medicine (U.S.).$bCommittee on New Frontiers in Contraceptive Research.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910966019903321
996   $aNew frontiers in contraceptive research$94369113
997   $aUNINA